Use of omega-3 fatty acid(s) for treating hypercholesterolemia caused by antiretroviral treatment of HIV-infected patients

Details for Australian Patent Application No. 2005311266 (hide)

Owner Pierre Fabre Medicament

Inventors Gardette, Jean

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005311266

PCT Pub. Number WO2006/058920

Priority 0412862 03.12.04 FR

Filing date 2 December 2005

Wipo publication date 8 June 2006

International Classifications

A61K 31/202 (2006.01)

A61K 35/60 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 36/00 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/058920 Priority application(s): WO2006/058920

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005311269-Heteroaromatic glucokinase activators

2005311251-5-carboxamido substituted thiazole derivatives that interact with ion channels, in particular with ion channels from the Kv family